Competitive Advantages
- Protects healthy cells from exposure to toxic drugs
- Targeted drug delivery effectively supplies safe dosage to site of disease
- Improves post-treatment prognosis and may prevent cancer recurrence
Summary
Our researchers have developed a device with the ability to deliver precise and effective dosage quantities to a targeted site through direct vaginal delivery. This allows for accurate dosage delivery to identified cancerous cells in the ovaries as well as anywhere in the peritoneal cavity. The device consists of three components: a chamber, a drug tubing releaser, and a drug plunger. This novel device has the potential to be used for the treatment of ovarian cancer, but it may be used to treat other disease of the peritoneal cavity as well.
The Non-Invasive Drug Delivery Device Consists of Three Component Parts
Desired Partnerships
- License
- Sponsored Research
- Co-Development